Literature DB >> 1640812

Effects of endothelin on microcirculation of the pancreas.

K Takaori1, K Inoue, M Kogire, S Higashide, T Tun, T Aung, R Doi, N Fujii, T Tobe.   

Abstract

Endothelin, a newly described endothelial-derived peptide, has potent vasoconstrictive properties and has been speculated to play a physiological role in the regulation of blood flow in some organs. The present study was designed to evaluate the effects of endothelin-1, endothelin-2 and endothelin-3 on the pancreatic microcirculation. Pancreatic tissue blood flow was measured by a laser Doppler flow meter in anesthetized dogs and endothelin-1, endothelin-2 or endothelin-3 was injected intravenously in graduated doses. Endothelins induced dose-dependent decreases in pancreatic tissue blood flow. Endothelin-1, endothelin-2 and endothelin-3 at a dose of 100 pmol/kg reduced pancreatic blood flow by 45.4%, 19.6% and 51.9%, respectively, whereas systemic arterial blood pressure was not significantly affected. When endothelin-3 was administered at a dose of 1000 pmol/kg, pancreatic blood flow was decreased by 73.5% with a concomitant increase of systemic arterial blood pressure by 17.6%. Endothelins potently decreased pancreatic tissue blood flow, suggesting a possible role of these agents in regulating the pancreatic microcirculation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640812     DOI: 10.1016/0024-3205(92)90231-d

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Endothelin mediated nitric oxide effects in ischemia--reperfusion associated with pancreas transplantation.

Authors:  G Hotter; F Pi; C Sanz; C Peralta; N Prats; E Gelpi; F Badosa; L Fernández-Cruz; J Roselló-Catafau
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

2.  Differential effects of ET-1, ET-2, and ET-3 on pancreatic microcirculation, tissue integrity, and inflammation.

Authors:  T Plusczyk; B Bersal; M D Menger; G Feifel
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

3.  Intragastric alcohol causes endothelin release from feline pancreas.

Authors:  M P Lewis; P U Reber; A M Kusske; M T Toyama; K E Todd; S W Ashley; H A Reber
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

4.  The endothelin antagonist bosentan does not improve survival in severe experimental pancreatitis in rats.

Authors:  F Fiedler; D Ayasse; P Rohmeiss; N Gretz; C Rehbein; V Keim
Journal:  Int J Pancreatol       Date:  1999-12

5.  Endothelin-1 is a candidate mediating intestinal dysmotility in patients with acute pancreatitis.

Authors:  C Y Chen; C L Lu; F Y Chang; R H Lu; W W Ng; S D Lee
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

6.  Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis.

Authors:  G Eibl; H G Hotz; J Faulhaber; M Kirchengast; H J Buhr; T Foitzik
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

7.  Protective effects of endothelin-1 on acute pancreatitis in rats.

Authors:  M Kogire; K Inoue; S Higashide; K Takaori; Y Echigo; Y J Gu; S Sumi; K Uchida; M Imamura
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

8.  Endothelin-1 mediates the alcohol-induced reduction of pancreatic capillary blood flow.

Authors:  T Foitzik; H G Hotz; B Hot; M Kirchengast; H J Buhr
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

9.  Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis.

Authors:  T Foitzik; J Faulhaber; H G Hotz; M Kirchengast; H J Buhr
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

10.  Endothelin(A) receptor blockade reduces ischemia/reperfusion injury in pig pancreas transplantation.

Authors:  Helmut Witzigmann; Stefan Ludwig; Barbara Armann; Gäbor Gäbel; Daniel Teupser; Jürgen Kratzsch; Uta Carolin Pietsch; Andrea Tannapfel; Felix Geissler; Johann Hauss; Dirk Uhlmann
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.